Cargando…
Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets
Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) inc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478122/ https://www.ncbi.nlm.nih.gov/pubmed/36120460 http://dx.doi.org/10.3389/fendo.2022.947294 |
_version_ | 1784790497412251648 |
---|---|
author | Mengstie, Misganaw Asmamaw Abebe, Endeshaw Chekol Teklemariam, Awgichew Behaile Mulu, Anemut Tilahun Teshome, Assefa Agegnehu Zewde, Edgeit Abebe Muche, Zelalem Tilahun Azezew, Muluken Teshome |
author_facet | Mengstie, Misganaw Asmamaw Abebe, Endeshaw Chekol Teklemariam, Awgichew Behaile Mulu, Anemut Tilahun Teshome, Assefa Agegnehu Zewde, Edgeit Abebe Muche, Zelalem Tilahun Azezew, Muluken Teshome |
author_sort | Mengstie, Misganaw Asmamaw |
collection | PubMed |
description | Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) including heart failure cause significant morbidity and mortality worldwide. Concurrent hypertensive heart disease and/or coronary artery disease have been thought to be the causes of diabetic heart failure in DM patients. However, heart failure is extremely common in DM patients even in the absence of other risk factors such as coronary artery disease and hypertension. The occurrence of diabetes-induced heart failure has recently received a lot of attention. Understanding how diabetes increases the risk of heart failure and how it mediates major cellular and molecular alteration will aid in the development of therapeutics to prevent these changes. Hence, this review aimed to summarize the current knowledge and most recent findings in cellular and molecular mechanisms of diabetes-induced heart failure. |
format | Online Article Text |
id | pubmed-9478122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94781222022-09-17 Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets Mengstie, Misganaw Asmamaw Abebe, Endeshaw Chekol Teklemariam, Awgichew Behaile Mulu, Anemut Tilahun Teshome, Assefa Agegnehu Zewde, Edgeit Abebe Muche, Zelalem Tilahun Azezew, Muluken Teshome Front Endocrinol (Lausanne) Endocrinology Diabetes Mellitus (DM) is a worldwide health issue that can lead to a variety of complications. DM is a serious metabolic disorder that causes long-term microvascular and macro-vascular complications, as well as the failure of various organ systems. Diabetes-related cardiovascular diseases (CVD) including heart failure cause significant morbidity and mortality worldwide. Concurrent hypertensive heart disease and/or coronary artery disease have been thought to be the causes of diabetic heart failure in DM patients. However, heart failure is extremely common in DM patients even in the absence of other risk factors such as coronary artery disease and hypertension. The occurrence of diabetes-induced heart failure has recently received a lot of attention. Understanding how diabetes increases the risk of heart failure and how it mediates major cellular and molecular alteration will aid in the development of therapeutics to prevent these changes. Hence, this review aimed to summarize the current knowledge and most recent findings in cellular and molecular mechanisms of diabetes-induced heart failure. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9478122/ /pubmed/36120460 http://dx.doi.org/10.3389/fendo.2022.947294 Text en Copyright © 2022 Mengstie, Abebe, Teklemariam, Mulu, Teshome, Zewde, Muche and Azezew https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Mengstie, Misganaw Asmamaw Abebe, Endeshaw Chekol Teklemariam, Awgichew Behaile Mulu, Anemut Tilahun Teshome, Assefa Agegnehu Zewde, Edgeit Abebe Muche, Zelalem Tilahun Azezew, Muluken Teshome Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title | Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title_full | Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title_fullStr | Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title_full_unstemmed | Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title_short | Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets |
title_sort | molecular and cellular mechanisms in diabetic heart failure: potential therapeutic targets |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478122/ https://www.ncbi.nlm.nih.gov/pubmed/36120460 http://dx.doi.org/10.3389/fendo.2022.947294 |
work_keys_str_mv | AT mengstiemisganawasmamaw molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT abebeendeshawchekol molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT teklemariamawgichewbehaile molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT muluanemuttilahun molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT teshomeassefaagegnehu molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT zewdeedgeitabebe molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT muchezelalemtilahun molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets AT azezewmulukenteshome molecularandcellularmechanismsindiabeticheartfailurepotentialtherapeutictargets |